Ladenburg Thalmann Financial Services’s Aerie Pharmaceuticals AERI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$9K	Buy	397 +47	+13%	+$973	﹤0.01%	4554
2019 Q3	$7K	Buy	350 +263	+302%	+$6.03K	﹤0.01%	4569
2019 Q2	$2K	Sell	87 -38	-30%	-$1.46K	﹤0.01%	5032
2019 Q1	$6K	Buy	125 +106	+558%	+$4.67K	﹤0.01%	4608
2018 Q4	$1K	Buy	+19	New	+$891	﹤0.01%	5131
2017 Q4	–	Sell	-4,200	Closed	-$204K	–	5159
2017 Q3	$204K	Buy	+4,200	New	+$229K	﹤0.01%	2093
2015 Q4	–	Sell	-501	Closed	-$9K	–	4825
2015 Q3	$9K	Sell	501 -11	-2%	-$199	﹤0.01%	3618
2015 Q2	$9K	Buy	512 +350	+216%	+$6.42K	﹤0.01%	3777
2015 Q1	$5K	Hold	162	–	–	﹤0.01%	4003
2014 Q4	$4K	Buy	+162	New	+$4.11K	﹤0.01%	3847

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AERI Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Aerie Pharmaceuticals (AERI) stake by 13% in Q4 2019, buying an estimated $973 and bringing the position to 397 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #4554.

Ladenburg Thalmann Financial Services first reported a position in AERI in Q4 2014 and has held it in 10 quarters since. The position peaked at $204K in Q3 2017. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

Ladenburg Thalmann Financial Services held 397 shares of Aerie Pharmaceuticals worth $9K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 47 Aerie Pharmaceuticals shares in Q4 2019, an estimated $973.
Aerie Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4554 holding.
Ladenburg Thalmann Financial Services first reported a position in Aerie Pharmaceuticals in Q4 2014 and has held it in 10 quarters since.
Ladenburg Thalmann Financial Services's Aerie Pharmaceuticals position peaked at $204K in Q3 2017.
167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.